Cargando…
Chemotherapy with cytochalasin congeners in vitro and in vivo against murine models
Background Despite inherent differences between the cytoskeletal networks of malignant and normal cells, and the clinical antineoplastic activity of microtubule-directed agents, there has yet to be a microfilament-directed agent approved for clinical use. One of the most studied microfilament-direct...
Autores principales: | Trendowski, Matthew, Mitchell, Joan M., Corsette, Christine M., Acquafondata, Christopher, Fondy, Thomas P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4387261/ https://www.ncbi.nlm.nih.gov/pubmed/25563824 http://dx.doi.org/10.1007/s10637-014-0203-5 |
Ejemplares similares
-
Chemotherapy in vivo against M109 murine lung carcinoma with cytochalasin B by localized, systemic, and liposomal administration
por: Trendowski, Matthew, et al.
Publicado: (2015) -
Effects of cytochalasin congeners, microtubule-directed agents, and doxorubicin alone or in combination against human ovarian carcinoma cell lines in vitro
por: Trendowski, Matthew, et al.
Publicado: (2015) -
Preparation, In Vivo Administration, Dose-Limiting Toxicities, and Antineoplastic Activity of Cytochalasin B
por: Trendowski, Matthew, et al.
Publicado: (2015) -
Effects of mTOR inhibitors and cytoskeletal-directed agents alone and in combination against normal and neoplastic hematopoietic cells in vitro
por: Trendowski, Matthew, et al.
Publicado: (2015) -
Using Cytochalasins to Improve Current Chemotherapeutic Approaches
por: Trendowski, Matthew
Publicado: (2015)